https://www.selleckchem.com/products/zeocin.html
in non-significant improved progression-free survival compared with other regimens, suggesting potential independent mechanisms of resistance between PARP inhibitor and platinum compounds. Platinum doublet chemotherapy resulted in non-significant improved progression-free survival compared with other regimens, suggesting potential independent mechanisms of resistance between PARP inhibitor and platinum compounds. In patients treated for advanced ovarian cancer not suitable for complete primary surgery, interval surgery after three course
Like
Comment
Share
